Evonik expands lipids production to support Pfizer/BioNTech COVID-19 vaccine
12.02.2021
MOSCOW (MRC) -- Evonik Industries says it is expanding its partnership with BioNTech (Mainz, Germany) to increase supply security for the Pfizer-BioNTech COVID-19 vaccine and is investing in a short-term production expansion for specialty lipids, essential for messenger ribonucleic acid (mRNA) COVID-19 vaccines, reported Chemweek. The company says that "commercial lipid quantities" are to